# Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma

> **NCT01677468** · NA · UNKNOWN · sponsor: **Hallym University Medical Center** · enrollment: 250 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Transarterial Chemoembolization

## Interventions

- **PROCEDURE:** Intermediate embolization
- **PROCEDURE:** Complete embolization

## Key facts

- **NCT ID:** NCT01677468
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2012-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677468, "Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01677468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*